Spa Infinite Comp 18may12
Spa Infinite Comp 18may12
Spa Infinite Comp 18may12
Infinite Computers
LOOKING UP Sensex: 16328 CMP: INR 86.2 Target: INR 190.0 Information Technology
Infinite came out with its 4QFY12 results, in-line with our estimates. The company has shown positive volume growth of 0.5% to $53.1mn after two quarters of sequential decline. The FY12 revenue of $220.7mn and EPS of INR 27.7 exceeded company's guidance. The company has guided towards a 30% USD revenue growth in FY13E. We expect the company to exceed their EPS guidance of INR 34.3 in FY13E growing at 25.2%. With higher than industry average growth rates we expect a rerating of the stock from the current 3x LTM PE multiple to 5x with a target price of INR 190.
4QFY12 and FY12 Revenues - return to growth The company witnessed a sequential revenue growth of 0.5% in 4QFY12 to $53.1mn (3.1% decline YoY). The onsite pricing declined by 1.5% with stable offshore pricing. FY12 revenues of $220.7mn (SPAe: $220mn) grew 14% on the back of growth from BFSI and healthcare verticals (Others, up by 229% YoY). Margins decline Infinite witnessed a 468bps decline in EBITDA Margins for 4QFY12 (15.3%) over 3QFY12 due to (i) higher one-time contract manpower cost with one of the largest customer's transition project coming to end and (ii) INR appreciation. In FY12 the EBITDA Margins expanded by 59bps to 17.3% but higher tax outgo caused a lower PAT growth of 12.6% to INR 1,207mn Growth Avenues The company has hinted towards a USD revenue growth rate, higher than industry growth rate, at 30% for FY13E. The EBITDA Margins are expected to be lower at 16% from the FY12 margins of 17.3% as the company expects to invest the surplus into extending its next generation 3G messaging platforms products.
We expect the company to meet its revenue guidance on the back of higher growth from recent deal wins and product launches. Outlook and Valuation Infinite has exceeded its FY12 revenues and margin guidance on the back of higher growth from BFSI and Healthcare verticals and INR depreciation. We expect the growth momentum to continue on the back of marquee deals (Messaging Platform) and products (to be launched in 2QFY13). We have factored in a USD revenue growth of 21%/25% for FY13E/FY14E. We expect the margins to come off a bit due to (i) higher product investments (ii) Visa Costs hence contract manpower increasing and (iii) Wage Inflation though partially offset by INR depreciation. We have factored EBITDA Margins of 16.9%/17.7% for FY13E and FY14E. Thus on the back of higher than industry growth, stable margins and exceeding company's guidance, we expect the stock to be re-rated upwards. We continue to recommend BUY for the stock with a 2 year target price of INR 190.0 based on 5x FY14E earnings of INR 38.
Shareholding (%)
Promoters FIIs DIIS Others
Mar-12
66.62 10.90 5.54 16.94
Key Data
BSE Code NSE Code Bloomberg Code Reuters Code Shares Outstanding (Mn) 533154 INFINITE ICSL IN INFI.NS 44.0 10.0 3,705.8 169.9 / 56.2 8,450.0 34.9% 1.0
(INR mn)
Net Sales Growth (%) EBIDTAM (%) Adj. PAT Growth (%) Adj. EPS (INR) P/E (x) EV/EBIDTA EV/Sales RoIC (%) RoCE (%)
FY11
8,833 32.96% 16.74% 1,072 35.31% 24 3.46 4.63 0.77 21.84 28.84
FY12
10,558 19.53% 17.33% 1,207 12.63% 27 3.07 3.32 0.58 21.04 26.46
FY13E
13,611 28.91% 16.94% 1,511 25.17% 34 2.45 2.67 0.45 22.67 27.71
FY14E
15,354 12.81% 17.71% 1,673 10.72% 38 2.22 2.09 0.37 23.48 26.02
Face Value Mcap (INR Mn) 52 Week H/L 2W Avg. Qty, NSE+BSE Free Float (%) Beta
Infinite
Sensex
Amit Aggarwal
amit.aggarwal@spagroupindia.com Ph. No. 91 4289 5600 Ext.632
Revenues (USD Mn) Revenues (INR Mn) Less: Employee Cost Less: Contract Manp. Cost Gross Profit Gross Margins Less: Other Oper. Exp. EBIDTA EBIDTA Margins Less: Depreciation EBIT EBIT Margins Less: Interest Charges Add: Forex Gain / (Loss) Add: Other Income PBT Less: Taxes Tax Rate PAT PAT Margins EPS (Diluted)
-47.33% -47.14%
27.89% 28.71%
2.54% 3.36%
-0.79% -0.02%
11.68% 11.26%
-31.48% -29.69%
Telecom & Media Manufacturing Healthcare Energy and Utilities Retail Other
Q1FY12 2,881 1,061 303 55 270 4,570 3,451 1,119 (236) 85.0 19.7
Q2FY12 2,600 1,205 276 65 277 4,423 3,152 1,271 (147) 91.0 19.2
Q3FY12 2,331 1,201 273 60 278 4,143 2,869 1,274 (280) 90.0 21.5
Q4FY12 2,156 1,288 225 61 258 3,988 2,630 1,358 (155) 90.0 18.2
Offshore Revenue
Fig. 13: Onsite Pricing took a dip keeping offshore pricing stable.
80 70 60 50 40 30 20 10 0 Q4FY10 Q2FY11 Q4FY11 Q2FY12 Q4FY12 21.7 21.0 20.3 19.6 18.9 18.2 17.5
Fig. 11: . . . but higher Contract Manpower cost, lowers operating margins . . . .
35% 28% 21% 14% 7% 0% Q2FY11 Q3FY11 Q4FY11 Q1FY12 Q2FY12 Q3FY12 Q4FY12 Operating Margins
Source: Company, SPA Research
Fig. 14: Lower non-linear revenues (IMS and IP) caused the margins dip but acts as a future margin tailwind.
14 12 10 8 6 4 2 0 Q4FY10 Q2FY11 Q4FY11 IP Leveraged
Source: Company, SPA Research
Q2FY12 IMS
Q4FY12
Information Technology Fig. 15: After 2 quarters of sequential revenue decline, revenue grew in 4QFY12, though employee growth continued to decline.
20% 15% 10% 5% 0% -5% -10% Q4FY10 Q2FY11 Q4FY11 Q2FY12 Q4FY12
Inremental Growth Incremental top 10 client growth
Source: Company, SPA Research
Fig. 17: Revenue grew outside the top 10 clients who actually showed degrowth.
8 6 4 2 0 -2 -4 -6 Q4FY10 Q2FY11 Q4FY11 Q2FY12 Q4FY12
Employee Growth
Source: Company, SPA Research
Fig. 16: T&M revenue share declined with increase in Revenue sharing and Fixed Bid projects.
45% 36% 27% 18% 9% 0% Q4FY10 Q2FY11 Q4FY11 Q2FY12 Fixed Bid Q4FY12 Revenue Sharing
Source: Company, SPA Research
Q3FY12
Q4FY12
Net Block CWIP Goodwill Investments Current Assets Current Liabilities Net Current Assets Deferred Tax Assets Application of Funds
Key Ratio Year End March Per Share Data (INR) Reported EPS Adj. EPS Growth (%) CEPS DPS BVPS FCFPS EVAPS Return Ratios (%) RoNW RoIC Du Pont Analysis Tax Burden Interest Burden Sales Turnover Asset Turnover Debt Liabilities RoE Valuation Ratios P/E (x) P/BV (x) PEG (x) EV/ Sales (x) EV/EBIDTA (x) Payout Ratio (%) FY11 24 24 26.48% 23 3 95 (3) 12 28.84 21.84 79.02% 103.42% 0.15 2.07 1.16 28.84% 3.46 0.89 13.06 0.77 4.63 12.31% FY12 27 27 12.63% 26 7 113 34 12 26.46 21.04 75.12% 107.02% 0.14 2.06 1.14 26.46% 3.07 0.75 24.31 0.58 3.32 33.93% FY13E 34 34 25.17% 32 7 135 19 17 27.71 22.67 74.00% 105.86% 0.14 2.26 1.11 27.71% 2.45 0.62 9.74 0.45 2.67 34.85% FY14E 38 38 10.72% 39 7 157 32 21 27.87 23.48 75.00% 98.45% 0.15 2.21 1.09 26.02% 2.22 0.54 20.67 0.37 2.09 41.97%
Cash Flow Year End March (INR mn) EBT Less: Other Income/Excp. Add: Depreciation Add: Interest Paid Less: Taxes Paid Change in Working Capital Others CFs from Operations (a) Change in Fixed Assets Change in Investments Others CFs from Investments (b) Change in Equity Change in Debt Dividend Paid Interest Paid CFs from Financing (c) Change in Cash (a+b+c) Opening Cash Exchange Difference Closing Cash FCF FY11 1,356 167 17 (285) (370) 885 (986) 596 (390) (17) (17) (34) 461 548 1,010 (118) FY12 1,607 329 19 (400) 374 1,928 (437) (477) (410) (1,324) (60) (19) (79) 526 1,010 1,536 1,473 FY13E 2,042 377 21 (531) (253) 1,656 (800) (375) (527) (1,702) (50) (21) (71) (117) 1,536 1,419 835 FY14E 2,230 454 35 (558) 242 1 2,405 (950) (240) (702) (1,892) (30) (35) (65) 448 1,419 1,867 1,419
Information Technology
Sharad Avasthi
sharad.avasthi@spagroupindia.com
Ext.832
Disclaimer: This report is for the personal information of the authorized recipient and does not construe to be any investment, legal or taxation advice to you. SPA Securities Limited (hereinafter referred as SPA) is not soliciting any action based upon it. This report is not for public distribution and has been furnished to you solely for your information and should not be reproduced or redistributed to any other person in any form. This document is provided for assistance only and is not intended to be and must not alone be taken as the basis for an investment decision. The intent of this document is not in recommendary nature. The views expressed are those of analyst and the Company may or may not subscribe to all the views expressed therein The report is based upon information that we consider reliable, but we do not represent that it is accurate or complete, and it should not be relied upon such. SPA or any of its affiliates or employees shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. Neither the Firm, not its directors, employees, agents or representatives shall be liable for any damages whether direct or indirect, incidental, special or consequential including lost revenue or lost profits that may arise from or in connection with the use of the information. SPA or any of its affiliates or employees do not provide, at any time, any express or implied warranty of any kind, regarding any matter pertaining to this report, including without limitation the implied warranties of merchantability, fitness for a particular purpose, and non-infringement. The recipients of this report should rely on their own investigations. SPA and/or its affiliates and/or employees may have interests/ positions, financial or otherwise in the securities mentioned in this report. SPA has incorporated a Disclosure of Interest Statement in this document. This should, however, not be treated as endorsement of the views expressed in the report. Disclosure of Interest Statement 1. Analyst ownership of the stock 2. Group/Directors ownership of the stock 3. Broking relationship with company covered - No - No - No
This information is subject to change without any prior notice. SPA reserves the right to make modifications and alternations to this statement as may be required from time to time. Nevertheless, SPA is committed to providing independent and transparent recommendations to its clients, and would be happy to provide information in response to specific client queries.
SPA Securities Limited : SPA House, Nyay Sagar, Near Gurunanak Hospital, Bandra (E), Mumbai - 400051, Tel. No. : +91-022-4289 5600
For More Information Visit Us At : www.spasecurities.com
SPA CAPITAL SERVICES LIMITED SPA COMTRADE PRIVATE LIMITED Investment Advisory services, AMFI Reg. No. ARN-0007 Member of NCDEX & MCX. NCDEX TMID-00729, NCDEX FMC No.NCDEX/TCM/CORP/0714 SPA MERCHANT BANKERS LTD. SEBI registered Category-1 Merchant Bankers SEBI Regn. No. INM000010825 SPA INSURANCE BROKING SERVICES LTD. Direct Broker for Life and General Insurance Broking IRDA Lic. Code No. DB053/03
SPA Securities Ltd NSE Cash NSE Future & Option NSE Currency Derivatives BSE Cash BSE Currency Derivatives MCX-SX Currency Derivatives OTCEI PMS CDSL DP NSDL DP
SEBI Reg. Nos. INB231178238 INF231173238 INE231178238 INB011178234 INE011178234 INE261178238 INB200891838 INP000003179 IN-DP-CDSL-485-2008 IN-DP-NSDL-316-2009